PRPH — Prophase Labs Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual cashflow statement for Prophase Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	PRESS
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	6.27	18.5	-16.8	-53.4	-13.4
Depreciation
Deferred Taxes
Non-Cash Items	7.62	10.5	4.84	3.73	0.494
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-30.7	-5.1	1.31	18.8	-0.318
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-13.6	28.6	-11.9	-17.5	-8.34
Capital Expenditures	-4.23	-3.92	-2.08	-0.906	0
Purchase of Fixed Assets
Other Investing Cash Flow Items	-15.4	1.84	0.715	3.33	0.92
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-19.7	-2.08	-1.37	2.42	0.92
Financing Cash Flow Items	—	—	2.92	0.978	-0.035
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	35.1	-26	5.76	14.2	6.84
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1.84	0.451	-7.5	-0.931	-0.588